Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Steven Rosenberg

Concepts (596)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
57
2025
316
13.950
 Why?
Lymphocytes, Tumor-Infiltrating
62
2025
206
13.810
 Why?
Receptors, Antigen, T-Cell
55
2024
716
10.970
 Why?
Immunotherapy, Adoptive
53
2024
330
10.420
 Why?
T-Lymphocytes
47
2024
1975
7.300
 Why?
Melanoma
49
2024
760
7.100
 Why?
Neoplasms
35
2025
2698
5.320
 Why?
Gastrointestinal Neoplasms
8
2025
75
4.460
 Why?
CD8-Positive T-Lymphocytes
26
2023
907
3.850
 Why?
Autism Spectrum Disorder
22
2024
400
3.480
 Why?
Immunotherapy
16
2025
627
3.160
 Why?
Adoptive Transfer
18
2024
220
2.720
 Why?
Proto-Oncogene Proteins p21(ras)
8
2022
262
2.660
 Why?
Developmental Disabilities
13
2023
266
2.440
 Why?
Mutation
32
2025
3975
2.390
 Why?
Cancer Vaccines
8
2021
164
2.100
 Why?
Antigens, CD19
9
2022
123
2.040
 Why?
Programmed Cell Death 1 Receptor
9
2025
248
1.920
 Why?
CD4-Positive T-Lymphocytes
12
2022
1083
1.920
 Why?
Interleukin-2
7
2025
449
1.820
 Why?
Skin Neoplasms
13
2020
842
1.810
 Why?
Neoplasm Metastasis
18
2024
656
1.780
 Why?
Autistic Disorder
8
2024
205
1.720
 Why?
Humans
194
2025
136965
1.510
 Why?
ras Proteins
4
2021
150
1.430
 Why?
Colorectal Neoplasms
5
2025
812
1.360
 Why?
Neoplasm Proteins
7
2019
427
1.320
 Why?
Tumor Suppressor Protein p53
6
2022
522
1.270
 Why?
High-Throughput Nucleotide Sequencing
6
2025
539
1.230
 Why?
Epitopes, T-Lymphocyte
9
2021
182
1.190
 Why?
Eligibility Determination
3
2014
69
1.190
 Why?
Genetic Therapy
8
2022
297
1.160
 Why?
Lymphoma, B-Cell
4
2020
110
1.090
 Why?
Membrane Proteins
9
2019
1151
1.070
 Why?
Female
101
2025
73002
1.050
 Why?
Glioblastoma
2
2021
341
1.020
 Why?
Proto-Oncogene Proteins B-raf
4
2019
222
1.010
 Why?
Motor Skills Disorders
4
2016
29
0.990
 Why?
Child Development
7
2024
466
0.940
 Why?
Male
86
2025
67386
0.910
 Why?
Transcriptome
4
2022
966
0.900
 Why?
Middle Aged
56
2025
33226
0.890
 Why?
Genetic Engineering
6
2016
93
0.880
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2017
122
0.870
 Why?
HLA-A2 Antigen
11
2020
48
0.870
 Why?
Gene Expression Regulation, Neoplastic
7
2019
1382
0.850
 Why?
Cell Line, Tumor
26
2021
3393
0.840
 Why?
Coronary Artery Disease
6
2017
698
0.810
 Why?
Precision Medicine
3
2015
415
0.800
 Why?
Flow Cytometry
9
2018
1189
0.800
 Why?
T-Lymphocyte Subsets
5
2019
415
0.770
 Why?
Tumor Microenvironment
2
2019
667
0.760
 Why?
Ovarian Neoplasms
2
2019
566
0.760
 Why?
Medicare Part C
2
2013
32
0.750
 Why?
Cell Separation
4
2019
314
0.730
 Why?
Adult
46
2025
37715
0.720
 Why?
Single-Cell Analysis
3
2022
323
0.720
 Why?
HLA-DP beta-Chains
3
2019
85
0.700
 Why?
Interleukin-12
3
2020
120
0.690
 Why?
Receptors, Antigen
3
2015
16
0.680
 Why?
Cognition Disorders
2
2016
502
0.660
 Why?
Aged
35
2025
23803
0.660
 Why?
Hematopoietic Stem Cell Transplantation
3
2022
622
0.650
 Why?
HLA-A Antigens
2
2021
55
0.650
 Why?
Receptors, Antigen, T-Cell, alpha-beta
4
2020
335
0.640
 Why?
Antigen Presentation
8
2020
218
0.630
 Why?
Retroviridae
2
2022
102
0.620
 Why?
Mutation, Missense
2
2020
338
0.620
 Why?
Interleukin-15
2
2017
101
0.620
 Why?
Colonic Neoplasms
2
2019
250
0.620
 Why?
Mucin-4
1
2019
4
0.610
 Why?
Smad5 Protein
1
2019
8
0.610
 Why?
Temperament
1
2019
45
0.600
 Why?
Exome
7
2016
233
0.600
 Why?
Lymphocyte Depletion
2
2016
136
0.600
 Why?
Child, Preschool
29
2024
10952
0.590
 Why?
Immunity, Cellular
1
2020
267
0.590
 Why?
T-Lymphocytes, Regulatory
2
2019
384
0.590
 Why?
Cholangiocarcinoma
2
2023
95
0.580
 Why?
Bile Duct Neoplasms
2
2023
117
0.570
 Why?
Sequence Analysis, DNA
2
2021
824
0.570
 Why?
ErbB Receptors
2
2019
606
0.560
 Why?
Disease Susceptibility
1
2019
347
0.530
 Why?
Genetic Vectors
5
2022
321
0.530
 Why?
Family Characteristics
2
2018
191
0.530
 Why?
Antigens
1
2019
352
0.520
 Why?
RNA, Messenger
3
2020
2788
0.520
 Why?
History, 20th Century
4
2025
324
0.520
 Why?
Child Behavior
1
2019
245
0.520
 Why?
Social Behavior
2
2023
288
0.510
 Why?
History, 21st Century
3
2025
213
0.500
 Why?
Myocardial Perfusion Imaging
2
2013
39
0.500
 Why?
Awards and Prizes
1
2017
70
0.500
 Why?
Transposases
1
2016
19
0.490
 Why?
Communication
2
2023
911
0.490
 Why?
Cell Engineering
1
2016
14
0.490
 Why?
Gene Expression Profiling
8
2019
1747
0.480
 Why?
Self-Injurious Behavior
4
2018
131
0.480
 Why?
Bile Ducts, Intrahepatic
2
2023
64
0.470
 Why?
Lymphoma
1
2017
209
0.470
 Why?
Cell Cycle Checkpoints
1
2016
97
0.470
 Why?
Psychotherapy
1
2017
176
0.470
 Why?
Immunologic Memory
5
2024
353
0.460
 Why?
Surveys and Questionnaires
9
2024
5812
0.440
 Why?
Breast Neoplasms
3
2022
2266
0.420
 Why?
T-Cell Antigen Receptor Specificity
7
2020
50
0.420
 Why?
Lymphocytes
1
2016
389
0.420
 Why?
Lymphocyte Transfusion
1
2013
21
0.420
 Why?
Lymphocyte Activation
10
2020
1134
0.410
 Why?
Sentinel Lymph Node Biopsy
1
2014
113
0.410
 Why?
Th1 Cells
1
2014
141
0.410
 Why?
Vidarabine
4
2017
33
0.410
 Why?
Indoles
1
2016
406
0.410
 Why?
Leukemia
2
2016
240
0.400
 Why?
Plaque, Atherosclerotic
1
2014
57
0.400
 Why?
Animals
29
2024
36882
0.400
 Why?
Lymph Node Excision
1
2014
168
0.400
 Why?
Histocompatibility Antigens Class I
5
2021
203
0.400
 Why?
Transplantation Conditioning
4
2019
173
0.390
 Why?
Child
22
2024
21760
0.390
 Why?
Sulfonamides
1
2016
507
0.390
 Why?
Cyclophosphamide
4
2017
236
0.390
 Why?
Melanoma, Experimental
4
2020
111
0.380
 Why?
Stem Cell Transplantation
1
2013
177
0.380
 Why?
Cell- and Tissue-Based Therapy
3
2019
80
0.380
 Why?
Transfection
1
2014
934
0.370
 Why?
Mice
21
2024
17705
0.370
 Why?
Gene Expression
7
2016
1480
0.370
 Why?
Genes, T-Cell Receptor
3
2022
9
0.360
 Why?
Antibodies, Monoclonal
3
2017
1412
0.350
 Why?
Melanoma-Specific Antigens
3
2016
5
0.350
 Why?
Adaptor Proteins, Signal Transducing
1
2014
428
0.350
 Why?
Biomarkers, Tumor
6
2019
1229
0.340
 Why?
Neoplasms, Second Primary
2
2022
113
0.340
 Why?
Coronary Angiography
5
2017
314
0.340
 Why?
Treatment Outcome
15
2021
10664
0.340
 Why?
Case-Control Studies
13
2024
3556
0.340
 Why?
Transplantation, Autologous
3
2022
239
0.330
 Why?
Coculture Techniques
3
2021
240
0.330
 Why?
United States
16
2025
14945
0.330
 Why?
Receptor, ErbB-2
4
2016
341
0.330
 Why?
Lung Neoplasms
3
2022
2552
0.330
 Why?
gp100 Melanoma Antigen
5
2016
8
0.320
 Why?
Medicaid
1
2014
437
0.320
 Why?
Papillomaviridae
3
2019
130
0.320
 Why?
Child Development Disorders, Pervasive
2
2024
62
0.320
 Why?
Kidney Neoplasms
1
2014
395
0.320
 Why?
Infant
11
2017
9392
0.310
 Why?
Transduction, Genetic
4
2019
128
0.300
 Why?
Papillomavirus Infections
3
2018
376
0.300
 Why?
Combined Modality Therapy
5
2021
1215
0.290
 Why?
Human papillomavirus 16
3
2018
33
0.290
 Why?
Peptides
4
2020
975
0.290
 Why?
Phenotype
6
2024
3148
0.290
 Why?
Prospective Studies
8
2023
7512
0.290
 Why?
Repressor Proteins
3
2017
422
0.280
 Why?
Intellectual Disability
3
2024
165
0.280
 Why?
Antigens, Differentiation, T-Lymphocyte
2
2020
97
0.280
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
3
2017
26
0.270
 Why?
Cells, Cultured
8
2021
4136
0.270
 Why?
Algorithms
3
2015
1700
0.260
 Why?
Prevalence
8
2018
2732
0.260
 Why?
Dendritic Cells
4
2019
483
0.260
 Why?
Carcinoma, Squamous Cell
3
2017
645
0.260
 Why?
Neoplasm Staging
5
2018
1352
0.260
 Why?
Oncogene Proteins, Viral
2
2017
22
0.250
 Why?
Tomography, X-Ray Computed
6
2018
2654
0.250
 Why?
Lymphocyte Count
2
2016
147
0.250
 Why?
Cell Proliferation
8
2019
2456
0.250
 Why?
Young Adult
13
2020
13218
0.250
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2014
1680
0.250
 Why?
CD8 Antigens
2
2018
74
0.250
 Why?
Antigens, CD
3
2020
527
0.240
 Why?
Uterine Cervical Neoplasms
4
2018
287
0.240
 Why?
Carcinoma
2
2018
228
0.230
 Why?
National Cancer Institute (U.S.)
1
2025
50
0.230
 Why?
Tumor Cells, Cultured
5
2018
942
0.230
 Why?
Pilot Projects
5
2019
1730
0.230
 Why?
Whole-Body Irradiation
2
2016
78
0.230
 Why?
Brain Neoplasms
4
2018
1255
0.220
 Why?
Socioeconomic Factors
3
2018
1310
0.220
 Why?
DNA Transposable Elements
2
2016
122
0.220
 Why?
Longitudinal Studies
5
2016
2851
0.220
 Why?
T-Lymphocytes, Cytotoxic
2
2015
171
0.220
 Why?
Jaundice, Neonatal
1
2023
7
0.210
 Why?
Sensitivity and Specificity
3
2018
1923
0.210
 Why?
Adolescent
13
2023
21471
0.210
 Why?
Immunohistochemistry
4
2016
1706
0.210
 Why?
Disability Evaluation
3
2014
293
0.210
 Why?
Leukocytes, Mononuclear
3
2015
561
0.200
 Why?
Infant, Very Low Birth Weight
2
2014
68
0.200
 Why?
Protein Engineering
2
2014
107
0.200
 Why?
Problem Behavior
2
2022
103
0.200
 Why?
Proto-Oncogene Proteins
2
2017
622
0.200
 Why?
Parks, Recreational
1
2022
11
0.190
 Why?
Constriction, Pathologic
2
2014
238
0.190
 Why?
Time-to-Treatment
1
2024
203
0.190
 Why?
DNA-Binding Proteins
3
2019
1472
0.190
 Why?
Proteasome Endopeptidase Complex
2
2020
156
0.180
 Why?
Occupational Therapy
2
2014
99
0.180
 Why?
HEK293 Cells
5
2017
727
0.180
 Why?
Burkitt Lymphoma
1
2022
59
0.180
 Why?
Clone Cells
2
2019
263
0.180
 Why?
Amino Acid Sequence
4
2020
2139
0.180
 Why?
Sex Factors
4
2017
2060
0.180
 Why?
Oncogenes
2
2020
116
0.180
 Why?
Biomarkers
3
2019
4095
0.180
 Why?
Adaptation, Psychological
2
2024
669
0.180
 Why?
Genes, Tumor Suppressor
2
2019
80
0.180
 Why?
Exercise Test
2
2015
617
0.180
 Why?
Genes, T-Cell Receptor alpha
1
2021
12
0.170
 Why?
Pancreatic Neoplasms
2
2022
832
0.170
 Why?
Apyrase
1
2020
17
0.170
 Why?
Gene Expression Regulation
3
2019
2574
0.170
 Why?
Demography
3
2018
295
0.170
 Why?
Cytokines
6
2022
2070
0.170
 Why?
Lectins, C-Type
1
2020
64
0.170
 Why?
Epitope Mapping
2
2018
61
0.170
 Why?
Oncolytic Virotherapy
1
2020
14
0.170
 Why?
MART-1 Antigen
3
2014
12
0.170
 Why?
HLA Antigens
2
2021
238
0.170
 Why?
Multiple Myeloma
1
2023
263
0.170
 Why?
Physical Therapy Modalities
2
2014
307
0.170
 Why?
Psychotropic Drugs
1
2021
72
0.170
 Why?
Mice, Mutant Strains
1
2020
303
0.160
 Why?
Lymphatic Metastasis
2
2019
319
0.160
 Why?
Models, Immunological
1
2020
100
0.160
 Why?
Drug Utilization
1
2021
169
0.160
 Why?
Premature Birth
1
2023
334
0.160
 Why?
HLA-C Antigens
2
2020
35
0.160
 Why?
Follow-Up Studies
7
2020
5048
0.160
 Why?
Metastasectomy
2
2017
19
0.160
 Why?
Protein Binding
8
2020
2223
0.160
 Why?
Remission Induction
5
2020
287
0.160
 Why?
Amino Acid Substitution
1
2020
304
0.160
 Why?
Virus Replication
1
2022
518
0.160
 Why?
Antibodies, Monoclonal, Humanized
1
2025
798
0.160
 Why?
Gene Regulatory Networks
1
2022
309
0.160
 Why?
Age Factors
3
2024
3258
0.150
 Why?
Neoplasm Recurrence, Local
2
2017
1038
0.150
 Why?
Genes, Neoplasm
1
2019
22
0.150
 Why?
Cysteine
1
2020
202
0.150
 Why?
Alcohol Oxidoreductases
1
2019
62
0.150
 Why?
Gestational Age
2
2024
902
0.150
 Why?
Practice Patterns, Physicians'
2
2021
1295
0.150
 Why?
Prognosis
6
2020
3931
0.150
 Why?
Neoplasms, Glandular and Epithelial
1
2019
49
0.150
 Why?
Area Under Curve
3
2014
303
0.150
 Why?
Cell Line
4
2022
2855
0.150
 Why?
Referral and Consultation
4
2023
779
0.140
 Why?
Neoplastic Cells, Circulating
1
2019
79
0.140
 Why?
B-Lymphocytes
3
2020
845
0.140
 Why?
Cohort Studies
6
2016
5688
0.140
 Why?
Behavior Therapy
1
2021
270
0.140
 Why?
Trees
1
2018
72
0.140
 Why?
RGS Proteins
1
2018
18
0.140
 Why?
Medical Oncology
1
2020
299
0.140
 Why?
Ubiquitin Thiolesterase
1
2018
48
0.140
 Why?
Forkhead Transcription Factors
1
2019
198
0.140
 Why?
Education, Special
1
2017
24
0.140
 Why?
Mothers
1
2024
758
0.140
 Why?
Smoking
2
2018
1609
0.140
 Why?
Psychometrics
2
2019
721
0.140
 Why?
Lymphoma, Non-Hodgkin
1
2018
85
0.140
 Why?
Parents
4
2022
1412
0.130
 Why?
Uveal Neoplasms
1
2017
10
0.130
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2017
3
0.130
 Why?
Self-Examination
1
2017
2
0.130
 Why?
Hematologic Neoplasms
1
2019
157
0.130
 Why?
Recombinant Fusion Proteins
3
2015
660
0.130
 Why?
ROC Curve
3
2013
554
0.130
 Why?
Signal Transduction
5
2019
5047
0.130
 Why?
Societies, Scientific
1
2017
52
0.130
 Why?
Maternal Age
1
2017
127
0.130
 Why?
Interferon-gamma
5
2020
782
0.130
 Why?
Immunologic Surveillance
1
2017
26
0.130
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2017
171
0.130
 Why?
Administration, Intravenous
1
2017
152
0.130
 Why?
Carcinogenesis
1
2018
215
0.130
 Why?
Population Surveillance
2
2017
487
0.130
 Why?
fas Receptor
2
2015
96
0.130
 Why?
Disease Progression
5
2017
2708
0.130
 Why?
Tissue and Organ Procurement
1
2020
315
0.130
 Why?
CTLA-4 Antigen
1
2017
97
0.130
 Why?
Sialadenitis
1
2016
2
0.130
 Why?
Circulating Tumor DNA
1
2016
31
0.120
 Why?
WT1 Proteins
1
2016
15
0.120
 Why?
Peptidomimetics
1
2016
4
0.120
 Why?
Antineoplastic Agents
2
2017
2111
0.120
 Why?
Mitogen-Activated Protein Kinases
1
2017
314
0.120
 Why?
Logistic Models
4
2016
2066
0.120
 Why?
Green Fluorescent Proteins
2
2015
396
0.120
 Why?
HLA-DQ beta-Chains
1
2016
63
0.120
 Why?
Urinary Bladder Neoplasms
1
2019
253
0.120
 Why?
ras GTPase-Activating Proteins
1
2015
15
0.120
 Why?
Immunoglobulin A
1
2017
210
0.120
 Why?
Immunoglobulin M
1
2017
288
0.120
 Why?
Transplantation Chimera
1
2016
58
0.120
 Why?
Immunodominant Epitopes
1
2015
27
0.120
 Why?
Peer Group
1
2018
244
0.120
 Why?
Clonal Evolution
1
2016
45
0.120
 Why?
Coronary Vessels
2
2017
243
0.120
 Why?
Molecular Targeted Therapy
1
2019
402
0.120
 Why?
Proto-Oncogene Proteins c-akt
2
2015
436
0.120
 Why?
Cesarean Section
1
2017
184
0.120
 Why?
Psychoanalytic Therapy
1
1995
10
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
134
0.120
 Why?
Aged, 80 and over
3
2025
7559
0.120
 Why?
RNA, Neoplasm
1
2015
80
0.120
 Why?
Receptors, HIV
1
2015
24
0.120
 Why?
Epitopes
2
2015
476
0.120
 Why?
Zinc Fingers
1
2015
49
0.120
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
74
0.120
 Why?
Psychotherapy, Brief
1
1995
36
0.110
 Why?
Sarcoma, Synovial
1
2014
21
0.110
 Why?
Immunophenotyping
1
2016
323
0.110
 Why?
Immunity, Active
1
2014
10
0.110
 Why?
Alphapapillomavirus
1
2015
39
0.110
 Why?
Odds Ratio
2
2014
1071
0.110
 Why?
Neoplasms, Germ Cell and Embryonal
1
2016
77
0.110
 Why?
Language
1
2018
300
0.110
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2014
10
0.110
 Why?
Psychotherapy, Group
1
1995
74
0.110
 Why?
Endoribonucleases
1
2015
78
0.110
 Why?
Aspirin
1
2018
389
0.110
 Why?
Clinical Trials as Topic
5
2020
1019
0.110
 Why?
Metalloproteins
1
2014
6
0.110
 Why?
Managed Care Programs
1
1995
141
0.110
 Why?
Clinical Trials, Phase II as Topic
1
2014
70
0.110
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2014
30
0.110
 Why?
Triple Negative Breast Neoplasms
1
2017
203
0.110
 Why?
5' Untranslated Regions
1
2014
57
0.110
 Why?
Nitric Oxide Synthase Type I
1
2014
28
0.110
 Why?
Thrombotic Microangiopathies
1
2014
20
0.110
 Why?
Echocardiography, Stress
1
2013
23
0.110
 Why?
Ribosomal Proteins
1
2014
91
0.110
 Why?
Tumor Lysis Syndrome
1
2013
8
0.110
 Why?
MAP Kinase Kinase Kinase 5
1
2013
6
0.110
 Why?
Mice, Transgenic
5
2020
2156
0.100
 Why?
Transcription Factors
2
2019
1705
0.100
 Why?
Autografts
1
2013
44
0.100
 Why?
Thioredoxins
1
2013
30
0.100
 Why?
HLA-DR4 Antigen
1
2013
76
0.100
 Why?
Policy Making
1
2014
99
0.100
 Why?
Testis
1
2014
155
0.100
 Why?
Extremities
1
2014
130
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1100
0.100
 Why?
Motor Skills
1
2014
99
0.100
 Why?
Cross-Sectional Studies
5
2017
5530
0.100
 Why?
Health Care Reform
1
2014
106
0.100
 Why?
Cognition
2
2023
1171
0.100
 Why?
Gene Expression Regulation, Enzymologic
1
2014
275
0.100
 Why?
Allografts
1
2013
145
0.100
 Why?
Transcriptional Activation
1
2015
371
0.100
 Why?
Immunoglobulin G
1
2017
892
0.100
 Why?
Psychiatric Status Rating Scales
1
2015
549
0.100
 Why?
Interferon-alpha
1
2014
199
0.100
 Why?
Astrocytoma
1
2013
127
0.100
 Why?
Histones
1
2018
635
0.100
 Why?
Cell Movement
4
2019
964
0.100
 Why?
Nuclear Proteins
2
2015
705
0.100
 Why?
Likelihood Functions
1
2013
143
0.100
 Why?
Radiation Injuries
1
2014
147
0.100
 Why?
Nanotechnology
1
2013
123
0.100
 Why?
Infant, Newborn
4
2023
6051
0.090
 Why?
Esophageal Neoplasms
1
2016
317
0.090
 Why?
Survival Rate
4
2020
1882
0.090
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
232
0.090
 Why?
Receptors, N-Methyl-D-Aspartate
1
2014
218
0.090
 Why?
Risk Factors
5
2023
10363
0.090
 Why?
Calcinosis
1
2014
234
0.090
 Why?
Muscle Proteins
1
2013
229
0.090
 Why?
Sarcoma
1
2014
185
0.090
 Why?
Cost of Illness
1
2014
303
0.090
 Why?
Propensity Score
1
2013
304
0.090
 Why?
Risk Assessment
3
2019
3446
0.090
 Why?
Killer Cells, Natural
1
2014
448
0.090
 Why?
Prostatic Neoplasms
1
2019
1041
0.090
 Why?
Randomized Controlled Trials as Topic
2
2013
1460
0.090
 Why?
Research Design
2
2014
1114
0.090
 Why?
Genome, Human
1
2013
419
0.090
 Why?
Anxiety
1
2018
1052
0.090
 Why?
Head and Neck Neoplasms
1
2016
552
0.090
 Why?
Wounds and Injuries
1
2018
746
0.090
 Why?
Cytotoxicity, Immunologic
3
2016
222
0.080
 Why?
Health Policy
1
2014
396
0.080
 Why?
Xenograft Model Antitumor Assays
3
2020
862
0.080
 Why?
RNA-Binding Proteins
1
2014
424
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2014
971
0.080
 Why?
Genetic Testing
1
2013
455
0.080
 Why?
Decision Support Techniques
1
2013
420
0.080
 Why?
Models, Theoretical
1
2013
581
0.080
 Why?
Time Factors
2
2017
6786
0.080
 Why?
K562 Cells
2
2020
91
0.080
 Why?
HIV-1
1
2015
866
0.080
 Why?
Adenocarcinoma
1
2016
869
0.070
 Why?
Real-Time Polymerase Chain Reaction
3
2015
347
0.070
 Why?
Databases, Factual
3
2023
1367
0.070
 Why?
Protein Kinase Inhibitors
1
2014
901
0.070
 Why?
Colorado
2
2017
4542
0.070
 Why?
Coronary Stenosis
1
2008
38
0.070
 Why?
Arthritis, Rheumatoid
1
2017
1156
0.070
 Why?
RNA
1
2015
922
0.070
 Why?
Comorbidity
3
2018
1626
0.070
 Why?
Double-Blind Method
1
2013
1904
0.070
 Why?
Anti-HIV Agents
1
2015
817
0.070
 Why?
Apoptosis
2
2013
2542
0.070
 Why?
Neoplasm Transplantation
3
2015
250
0.070
 Why?
RNA, Small Interfering
3
2014
619
0.070
 Why?
Neutrophils
1
2013
1264
0.070
 Why?
Protective Factors
2
2017
94
0.070
 Why?
Faculty
1
2007
151
0.060
 Why?
Mass Screening
2
2020
1295
0.060
 Why?
Cross Reactions
2
2016
130
0.060
 Why?
DNA Mutational Analysis
2
2019
395
0.060
 Why?
Molecular Sequence Data
3
2015
2900
0.060
 Why?
Cardiovascular Diseases
1
2018
2115
0.060
 Why?
CD4 Antigens
2
2016
140
0.060
 Why?
Mice, Inbred C57BL
4
2020
5733
0.060
 Why?
Neutropenia
2
2017
152
0.060
 Why?
Mice, Inbred NOD
2
2018
596
0.060
 Why?
Retrospective Studies
5
2024
15536
0.060
 Why?
Single-Chain Antibodies
2
2015
17
0.060
 Why?
Protein Transport
2
2017
439
0.060
 Why?
Intercellular Junctions
2
2014
40
0.050
 Why?
Physical Examination
2
2017
240
0.050
 Why?
GPI-Linked Proteins
2
2014
75
0.050
 Why?
Parity
1
2024
126
0.050
 Why?
Lung
1
2016
4035
0.050
 Why?
Nerve Tissue Proteins
2
2020
592
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2023
27
0.050
 Why?
Exercise
1
2015
2064
0.050
 Why?
Point Mutation
2
2014
237
0.050
 Why?
Health Facilities
1
2023
84
0.050
 Why?
Autoantigens
2
2016
421
0.050
 Why?
Bone Marrow
1
2023
298
0.050
 Why?
Minority Groups
1
2024
272
0.050
 Why?
Receptors, Cell Surface
1
2004
391
0.050
 Why?
Cluster Analysis
2
2014
513
0.050
 Why?
Linear Models
1
2024
857
0.050
 Why?
Skin
2
2019
746
0.050
 Why?
Alleles
2
2015
885
0.050
 Why?
Severity of Illness Index
2
2023
2809
0.040
 Why?
Oligonucleotide Array Sequence Analysis
2
2014
756
0.040
 Why?
Educational Status
1
2023
473
0.040
 Why?
Recombinant Proteins
2
2014
1343
0.040
 Why?
Proportional Hazards Models
1
2024
1251
0.040
 Why?
Parenting
1
2024
315
0.040
 Why?
Models, Genetic
2
2013
586
0.040
 Why?
Predictive Value of Tests
2
2017
1999
0.040
 Why?
Jurkat Cells
1
2020
136
0.040
 Why?
Base Sequence
2
2014
2168
0.040
 Why?
Immunoglobulins
1
2020
168
0.040
 Why?
Cysteine Endopeptidases
1
2020
73
0.040
 Why?
Glioma
1
2004
399
0.040
 Why?
Early Diagnosis
1
2020
236
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
66
0.040
 Why?
Caregivers
2
2018
903
0.040
 Why?
Health Care Surveys
1
2021
564
0.040
 Why?
Hydrolysis
1
2019
193
0.040
 Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2018
3
0.040
 Why?
GTP Phosphohydrolases
1
2019
92
0.040
 Why?
Protein Domains
1
2020
289
0.040
 Why?
Cervix Uteri
1
2018
49
0.040
 Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
2018
18
0.040
 Why?
Forests
1
2018
63
0.040
 Why?
Nuclear Localization Signals
1
2017
18
0.030
 Why?
Uterine Cervical Dysplasia
1
2018
42
0.030
 Why?
Neoplasm Grading
1
2019
304
0.030
 Why?
Mice, SCID
1
2018
368
0.030
 Why?
Disulfides
1
2018
98
0.030
 Why?
Healthcare Disparities
1
2024
661
0.030
 Why?
Hydrogen Bonding
1
2018
167
0.030
 Why?
Platelet Aggregation
1
2018
103
0.030
 Why?
Ligands
2
2013
661
0.030
 Why?
Eye Enucleation
1
2017
12
0.030
 Why?
Human papillomavirus 18
1
2017
16
0.030
 Why?
Response Evaluation Criteria in Solid Tumors
1
2017
18
0.030
 Why?
Protein Stability
1
2018
175
0.030
 Why?
GTP-Binding Protein alpha Subunits
1
2017
16
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2017
20
0.030
 Why?
Culture Media, Serum-Free
1
2016
46
0.030
 Why?
Peptide Fragments
2
2015
690
0.030
 Why?
Lymphopenia
1
2017
63
0.030
 Why?
Drug Synergism
1
2017
368
0.030
 Why?
Vaccinia virus
1
2016
43
0.030
 Why?
Binding Sites
1
2020
1310
0.030
 Why?
Antigen-Presenting Cells
1
2017
157
0.030
 Why?
HLA-DRB1 Chains
1
2017
110
0.030
 Why?
Adenosine Triphosphate
1
2019
481
0.030
 Why?
Blood Chemical Analysis
1
2017
106
0.030
 Why?
Asymptomatic Diseases
1
2017
89
0.030
 Why?
Salivary Glands, Minor
1
2016
11
0.030
 Why?
Tissue Array Analysis
1
2016
51
0.030
 Why?
Health Surveys
1
2018
523
0.030
 Why?
Cell Membrane
1
2020
710
0.030
 Why?
Neoplasm Invasiveness
1
2018
495
0.030
 Why?
Leukemia, B-Cell
1
2016
13
0.030
 Why?
Radiotherapy
1
2017
204
0.030
 Why?
Fas Ligand Protein
1
2015
59
0.030
 Why?
HLA-A1 Antigen
1
2015
4
0.030
 Why?
Palate
1
2016
38
0.030
 Why?
Antigen-Antibody Reactions
1
2015
55
0.030
 Why?
Genes, erbB-2
1
2015
28
0.030
 Why?
Feasibility Studies
1
2020
965
0.030
 Why?
Machine Learning
1
2021
513
0.030
 Why?
Salvage Therapy
1
2016
138
0.030
 Why?
MAP Kinase Signaling System
1
2017
321
0.030
 Why?
Anemia
1
2017
171
0.030
 Why?
Interferon-gamma Release Tests
1
2015
32
0.030
 Why?
Anus Neoplasms
1
2015
34
0.030
 Why?
Health Promotion
1
2022
759
0.030
 Why?
Compulsive Behavior
1
2015
7
0.030
 Why?
Thrombocytopenia
1
2017
197
0.030
 Why?
DNA, Neoplasm
1
2015
158
0.030
 Why?
Necrosis
1
2016
243
0.030
 Why?
Coronary Occlusion
1
2015
19
0.030
 Why?
Cloning, Molecular
1
2016
534
0.030
 Why?
Gastrointestinal Diseases
1
2017
207
0.030
 Why?
HIV Envelope Protein gp120
1
2015
60
0.030
 Why?
Dermatitis
1
2014
19
0.030
 Why?
HIV Antibodies
1
2015
61
0.030
 Why?
Metabolic Clearance Rate
1
2014
107
0.030
 Why?
Desmoplakins
1
2014
21
0.030
 Why?
Income
1
2016
204
0.030
 Why?
Regression Analysis
1
2017
1007
0.030
 Why?
Protein Conformation
1
2018
939
0.030
 Why?
Transplantation, Homologous
1
2016
409
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
150
0.030
 Why?
Monophenol Monooxygenase
1
2014
8
0.030
 Why?
Comparative Genomic Hybridization
1
2014
29
0.030
 Why?
Cell Survival
1
2017
1124
0.030
 Why?
Nausea
1
2014
111
0.030
 Why?
Models, Statistical
1
2018
662
0.030
 Why?
Mice, Inbred BALB C
1
2017
1256
0.030
 Why?
Gene Library
1
2014
119
0.030
 Why?
National Institutes of Health (U.S.)
1
2014
129
0.030
 Why?
Random Allocation
1
2014
352
0.030
 Why?
MAP Kinase Kinase 4
1
2013
24
0.030
 Why?
Histocompatibility Antigens
1
2014
106
0.030
 Why?
Infusions, Intravenous
1
2014
392
0.030
 Why?
Substrate Specificity
1
2014
383
0.030
 Why?
Social Class
1
2016
282
0.030
 Why?
Graft vs Host Disease
1
2016
252
0.030
 Why?
Sleep Wake Disorders
1
2017
300
0.030
 Why?
Tumor Burden
1
2014
305
0.030
 Why?
X-Ray Diffraction
1
2013
104
0.030
 Why?
Lentivirus
1
2013
57
0.030
 Why?
Confidence Intervals
1
2014
331
0.030
 Why?
Radiotherapy, Adjuvant
1
2014
210
0.030
 Why?
Immunoenzyme Techniques
1
2013
206
0.030
 Why?
Immunoprecipitation
1
2013
152
0.030
 Why?
Fever
1
2014
304
0.030
 Why?
Structure-Activity Relationship
1
2014
566
0.020
 Why?
Health Services Accessibility
1
2021
994
0.020
 Why?
Reproducibility of Results
2
2012
3266
0.020
 Why?
Drug Administration Schedule
1
2014
749
0.020
 Why?
Models, Molecular
1
2018
1591
0.020
 Why?
Cotinine
1
2012
77
0.020
 Why?
Bias
1
2013
222
0.020
 Why?
Cost-Benefit Analysis
1
1995
578
0.020
 Why?
Histocompatibility Antigens Class II
1
2014
365
0.020
 Why?
DNA Primers
1
2013
506
0.020
 Why?
Receptors, Immunologic
1
2013
215
0.020
 Why?
Spleen
1
2014
514
0.020
 Why?
Bayes Theorem
1
2013
410
0.020
 Why?
Pregnancy
1
2023
6736
0.020
 Why?
Blotting, Western
1
2013
1216
0.020
 Why?
Liver Neoplasms
1
2017
748
0.020
 Why?
Diagnosis, Differential
1
2015
1470
0.020
 Why?
Multivariate Analysis
1
2014
1484
0.020
 Why?
Carrier Proteins
1
2014
734
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
2015
0.020
 Why?
Kinetics
1
2013
1635
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2015
1229
0.020
 Why?
Phosphorylation
1
2014
1746
0.020
 Why?
Infant, Premature
1
2014
572
0.020
 Why?
North Carolina
1
2008
116
0.020
 Why?
Germany
1
2008
125
0.020
 Why?
Self Report
1
2012
836
0.020
 Why?
Cell Differentiation
1
2015
1985
0.020
 Why?
Disease Models, Animal
1
2018
4276
0.020
 Why?
Vaccination
1
2016
1428
0.020
 Why?
Models, Biological
1
2014
1780
0.020
 Why?
MicroRNAs
1
2013
677
0.020
 Why?
Intelligence
1
2007
127
0.020
 Why?
Polymorphism, Single Nucleotide
1
2013
2142
0.010
 Why?
Receptors, Urokinase Plasminogen Activator
1
2004
15
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2004
29
0.010
 Why?
Transplantation, Heterologous
1
2004
195
0.010
 Why?
Species Specificity
1
2004
583
0.010
 Why?
Neovascularization, Pathologic
1
2004
295
0.010
 Why?
Mice, Nude
1
2004
690
0.010
 Why?
Down Syndrome
1
1987
484
0.010
 Why?
Polyethylene Glycols
1
2004
631
0.010
 Why?
Endothelium, Vascular
1
2004
925
0.010
 Why?
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (596) concept(s)
_
Co-Authors Expand Description
See all (11) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)